Monoclonal Gammopathy of Undetermined Significance
Research from National Institutes of Health provide new insights into monoclonal gammopathy of undetermined significance
Published in Blood Weekly, February 7th, 2008
In this recent report published in the journal Mayo Clinic Proceedings, researchers in the United States conducted a study "To determine the prevalence of monoclonal gammopathy of undetermined significance (MGUS), a precursor of multiple myeloma (MM), in Ghanaian men vs white men and to test for evidence to support an underlying race-related predisposition of the 2-fold higher prevalence of MGUS In African Americans vs whites. Between September 1, 2004, and September 30, 2006, 917 men (50-74 years) underwent In-person interviews and physical examinations."
"Serum samples from all participants were analyzed by electrophoresis performed on agarose gel; any serum...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-02-07)
More Articles from Blood Weekly
- Myeloma
Experimental procedure induces tolerance to mismatched kidney transplants - Pediatrics
Children's Hospital physicians publish review of transplant issues in patients with biliary atresia - Acute Myeloid Leukemia
Researchers from City Hospital detail new studies and findings in the area of acute myeloid leukemia - Acute Promyelocytic Leukemia
New acute promyelocytic leukemia study results from University of Sao Paulo described - Acute Promyelocytic Leukemia
Researchers' work from Royal Prince Alfred Hospital focuses on acute promyelocytic leukemia - Autoimmune Disease
Research from National Institutes of Health has provided new information about autoimmune disease - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
